Bristol-Myers Squibb Co (BMY)
60.02
+1.12
(+1.90%)
USD |
NYSE |
Mar 28, 16:00
60.00
-0.02
(-0.03%)
After-Hours: 20:00
Bristol-Myers Squibb Enterprise Value: 160.64B for March 28, 2025
View 4,000+ Financial Data Types:
Add
Browse
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Amgen Inc | 213.02B |
| Gilead Sciences Inc | 154.28B |
| Johnson & Johnson | 406.63B |
| Eli Lilly and Co | 769.05B |
| Merck & Co Inc | 248.88B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 72.00M |
| Revenue (Quarterly) | 12.34B |
| Total Expenses (Quarterly) | 11.83B |
| EPS Diluted (Quarterly) | 0.04 |
| Gross Profit Margin (Quarterly) | 61.01% |
| Profit Margin (Quarterly) | 0.58% |
| Earnings Yield | -7.36% |
| Operating Earnings Yield | 4.84% |
| Normalized Earnings Yield | 1.004 |